Disclosures for "Efficacy of Olanzapine as an Abortive Treatment for Status Migrainosus: A Retrospective Chart Review"
-
Dr. Khan has nothing to disclose.
-
Dr. Sardana has nothing to disclose.
-
Mr. Saim has nothing to disclose.
-
Mr. Vyas has nothing to disclose.
-
Dr. Synowiec has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amgen. Dr. Synowiec has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Synowiec has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Synowiec has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven.